Applied DNA Sciences, Inc.
APDN
$4.83
$0.3156.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.79M | 3.74M | 3.43M | 3.40M | 5.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.79M | 3.74M | 3.43M | 3.40M | 5.52M |
| Cost of Revenue | 2.25M | 2.27M | 2.41M | 2.55M | 3.64M |
| Gross Profit | 1.55M | 1.47M | 1.02M | 851.00K | 1.88M |
| SG&A Expenses | 10.98M | 11.00M | 11.45M | 12.07M | 12.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.83M | 16.94M | 17.46M | 18.32M | 19.95M |
| Operating Income | -13.04M | -13.20M | -14.02M | -14.92M | -14.44M |
| Income Before Tax | -7.47M | -8.63M | -7.09M | -7.39M | -12.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.47 | -8.63 | -7.09 | -7.39 | -12.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 108.50K | 99.90K | 95.80K | 102.20K | 86.30K |
| Net Income | -7.36M | -8.53M | -6.99M | -7.29M | -12.27M |
| EBIT | -13.04M | -13.20M | -14.02M | -14.92M | -14.44M |
| EBITDA | -12.66M | -12.74M | -13.33M | -13.98M | -13.27M |
| EPS Basic | -887.84 | -657.54 | -240.01 | -- | -- |
| Normalized Basic EPS | -205.90 | -188.53 | -149.54 | -- | -- |
| EPS Diluted | -887.84 | -657.54 | -240.01 | -- | -- |
| Normalized Diluted EPS | -205.90 | -188.53 | -149.54 | -- | -- |
| Average Basic Shares Outstanding | 173.90K | 55.70K | 13.70K | -- | -- |
| Average Diluted Shares Outstanding | 173.90K | 55.70K | 13.70K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |